Monotropein mitigates atherosclerotic plaque vulnerability through circ₀140736/miR-495/SIRPα-mediated efferocytosis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1CD47-SIRPα signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques2024 · 2 citations
2. 2Circ_0093887 upregulates CCND2 and SUCNR1 to inhibit the ox‐LDL‐induced endothelial dysfunction in atherosclerosis by functioning as a miR‐876‐3p sponge2021 · 20 citations
3. 3In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis2025
4. 4In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis2025
5. 5Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation2024 · 12 citations